Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta

R. J. Wenstrup, M. C. Willing, B. J. Starman, P. H. Byers

Research output: Contribution to journalArticle

83 Scopus citations

Abstract

We reviewed clinical and biochemical findings from 132 probands with nonlethal forms of osteogenesis imperfecta (OI) whose fibroblasts were sent to the University of Washington for diagnostic studies in the years 1981-1987. In cells from 86% of probands with nonlethal OI we identified biochemical alterations compatible with heterozygosity for a mutation that affected expression or structure of α chains of type I procollagen. We observed two major biochemical phenotypes. Cells from 40 probands (group A) secreted about half the normal amount of normal type I procollagen and no identifiable abnormal molecules; these patients were generally of normal stature, rarely had bone deformity or dentinogenesis imperfecta, and had blue sclerae. Cells from 74 probands (group B) produced and secreted normal and abnormal type I procollagen molecules; these patients were usually short and had bone deformity and dentinogenesis imperfecta, and many had grey or blue-grey sclerae. In cells from an additional 18 probands (group C) we were unable to identify altered type I procollagen synthesis or structure. Detection of these abnormalities has value in the determination of mode of inheritance and the prediction of clinical severity.

Original languageEnglish
Pages (from-to)975-982
Number of pages8
JournalAmerican journal of human genetics
Volume46
Issue number5
StatePublished - 1990

Fingerprint Dive into the research topics of 'Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta'. Together they form a unique fingerprint.

  • Cite this